Error message

The page you requested does not exist. For your convenience, a search was performed using the query events thu 01 nov 1600 lmb seminar series title follow.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Dr David Gilligan

    David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

  12. Mr David Thurtle

    Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

  13. Professor David Glover

    Our laboratory studies the regulation of progression through mitosis and meiosis in animal cells. The high degree of evolutionary conservation of these regulatory mechanisms means that findings in model organisms are readily applicable to human cells....

  14. Dr Roisin Owens

    Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

  15. Mr Thierry Lefebvre

    Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

  16. Professor Walid Khaled

    My laboratory works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on how the cell of origin affects the differentiation trajectory of nascent tumour cells and dictates changes...

  17. Dr Anita Chandra

  18. Mr Angelos Kolias

    Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University,...

  19. Dr Anne-Laure Vallier

    (tbc)

  20. Professor Tony Green

    Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...

  21. Dr Alex Samoshkin

    I have been a Translational Technology Manager in the University of Cambridge since 2017. My primary role is to connect researchers in technology/physical sciences with clinicians and academics to develop new collaborative translational projects. I...

  22. Dr Emma Beddowes

    Investigating the development and application of circulating free nucleic acids to breast cancer research.

  23. Mrs Bin Liu

    Clinical information system

  24. Dr Chiwen Chang

    1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.

  25. Dr Callum Campbell

  26. Dr Cedric Ghevaert

    Cedric Gevaert graduated from the medical school of the University Libre de Bruxelles in 1997 and subsequently became a fellow of the Royal College of Physicians, London (2000). He specialised in Haematology and became a fellow of the Royal College of...

  27. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

  28. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

  29. Professor Alan Warren

    Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...

  30. Dr Alasdair Russell

    Alasdair heads up a specialised team that provide a centralised ‘Hub’ for the innovation and application of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a pre-clinical setting. Further, we use these novel...

  31. Dr Alexey Larionov

    Hormonal treatment and resistance in Breast cancer Heritable cancer predisposition NGS data analysis

  32. Dr Andrew Bannister

    I have spent the last three decades generally messing around with chromatin with a special focus on histones and their modifications. My research has focused on identifying novel histone modifications together with characterization of the enzymes ...

  33. Dr Antony Rix

    Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of...

  34. Professor Anthony Davenport

    Our research group focuses on understanding the role of G-protein-coupled receptors (GPCRs, targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging using positron emission...

  35. Dr Alex Cagan

    My research seeks  to understand the somatic evolutionary processes that occur within our bodies as we age and their consequences for health.  Evolution is often considered  to be an almost imperceptibly slow process. However, the cells that...

  36. Dr Andre Neves

    As a chemical engineer, I enjoy translating basic science into novel biomedical technologies. I am interested in the use of molecular imaging techniques for early cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm...

  37. Dr John Lizhe Zhuang

    ... that initiate BO and OAC. Firstly, I have established a series of patient derided organoid models from normal tissues, BO, and OAC, and ...

  38. Professor Ming-Qing Du

    ... and molecular investigations. We have been undertaking a series of research programmes to elucidate the pathology, immunophenotype, and ...

  39. Dr David Fairen-Jimenez

    Our research concerns the study of the molecular mechanisms that control adsorption processes in porous materials. We are particularly interested in drug delivery systems, where nanotechnology has a fundamental impact to revolutionise cancer diagnosis...

  40. Miss Jamie McGinn

    Project title: Epithelial cell dynamics during postnatal growth; relevance for ...

  41. Dr Anny Wong

    ... treatment and investigations. She also specialises in the follow-up care of children who have finished their cancer treatment. ...

  42. Professor Kevin Brindle

    Magnetic resonance imaging (MRI) is a well-established, clinically applicable, tool for determining tissue morphology. The techniques of molecular imaging seek, through the use of appropriate probe molecules, to transfer into the MR image of tissue...

  43. Professor Charlotte Coles

    ... radiotherapy in patients at low risk of recurrence – in follow up: 2018 patients recruited; 71 UK centres 2. IMPORT HIGH : phase ... IMRT for patients at higher risk of recurrence - in follow up: 2617 patients recruited; 77 UK centres 3. PRIMETIME : ...

  44. Mrs Eva Serrao

    ... formed alanine and lactate as a probe to detect, grade and follow progression of precursor lesions of pancreatic cancer before any ...

  45. Miss Nicola Fearnhead

    Miss Nicola Fearnhead has been a Consultant Colorectal Surgeon at Addenbrooke's Hospital, Cambridge since 2006. She is a graduate of Pembroke College, Cambridge and Merton College, Oxford where she was a Rhodes Scholar. Surgical training was...

  46. Dr George Follows

    My laboratory research focuses on transcriptional regulation and chromatin structure. I maintain a supervisory role for a research assistant in Professor Green's laboratory, CIMR, funded through a personal LRF project grant. I have now taken a clinical...

  47. Dr Hannah Harrison

    ... risk-stratification for kidney cancer screening and follow-up. Her most rencet project, funded by CRUK, is investigating ...

  48. Professor Julie Ahringer

    We investigate the functions chromatin regulatory complexes implicated in human disease using the C. elegans model system. These include the histone deacetylase complex NuRD, the Retinoblastoma complex DRM, and a TIP60 histone acetyltransferase complex....

  49. Dr John Suckling

    Our research programme leverages two decades of advancements in magnetic resonance imaging and assocaited methodologies to accrue the evidence to inform the difficult discussions with patients with brain tumours, and their families, on the balance...

Pages